Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bray

Showing results (1011-1020 of 1,079) with videos related to

Pageof 108
Sort By:
Diabetologia|December 17, 2009
Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) studyR A DeFronzo, M A Banerji, G A Bray, et al.
Journal of Behavioral Medicine|March 3, 2010
Early behavioral adherence predicts short and long-term weight loss in the POUNDS LOST studyDonald A Williamson, Stephen D Anton, Hongmei Han, et al.
Diabetes Care|August 29, 2006
Effect of weight loss with lifestyle intervention on risk of diabetesRichard F Hamman, Rena R Wing, Sharon L Edelstein, et al.
The American Journal of Clinical Nutrition|July 14, 2001
Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) TrialE Obarzanek, F M Sacks, W M Vollmer, et al.
JAMA|April 10, 2003
Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging studyMark P Ettinger, Thomas W Littlejohn, Sherwyn L Schwartz, et al.
Diabetes|October 4, 2014
Factors affecting the decline in incidence of diabetes in the Diabetes Prevention Program Outcomes Study (DPPOS), Richard F Hamman, Edward Horton, et al.
International Journal of Hygiene and Environmental Health|December 21, 2020
Per- and polyfluoroalkyl substance plasma concentrations and metabolomic markers of type 2 diabetes in the Diabetes Prevention Program trialSusanna D Mitro, Jinxi Liu, Lindsay M Jaacks, et al.
Journal of the Endocrine Society|August 21, 2019
A Polygenic Lipodystrophy Genetic Risk Score Characterizes Risk Independent of BMI in the Diabetes Prevention ProgramShylaja Srinivasan, Kathleen A Jablonski, William C Knowler, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2016
Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOWDevjit Tripathy, Dawn C Schwenke, MaryAnn Banerji, et al.
AIDS Research and Human Retroviruses|June 9, 1998
Hematologic and virologic effects of lineage-specific and non-lineage-specific recombinant human and rhesus cytokines in a cohort of SIVmac239-infected macaquesS Z Bucur, D A Lackey, J W Adams, et al.
Pageof 108

Showing results (1011-1020 of 1,079) with videos related to

Sort By:
Pageof 108
Diabetologia|December 17, 2009
Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) studyR A DeFronzo, M A Banerji, G A Bray, et al.
Journal of Behavioral Medicine|March 3, 2010
Early behavioral adherence predicts short and long-term weight loss in the POUNDS LOST studyDonald A Williamson, Stephen D Anton, Hongmei Han, et al.
Diabetes Care|August 29, 2006
Effect of weight loss with lifestyle intervention on risk of diabetesRichard F Hamman, Rena R Wing, Sharon L Edelstein, et al.
The American Journal of Clinical Nutrition|July 14, 2001
Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) TrialE Obarzanek, F M Sacks, W M Vollmer, et al.
JAMA|April 10, 2003
Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging studyMark P Ettinger, Thomas W Littlejohn, Sherwyn L Schwartz, et al.
Diabetes|October 4, 2014
Factors affecting the decline in incidence of diabetes in the Diabetes Prevention Program Outcomes Study (DPPOS), Richard F Hamman, Edward Horton, et al.
International Journal of Hygiene and Environmental Health|December 21, 2020
Per- and polyfluoroalkyl substance plasma concentrations and metabolomic markers of type 2 diabetes in the Diabetes Prevention Program trialSusanna D Mitro, Jinxi Liu, Lindsay M Jaacks, et al.
Journal of the Endocrine Society|August 21, 2019
A Polygenic Lipodystrophy Genetic Risk Score Characterizes Risk Independent of BMI in the Diabetes Prevention ProgramShylaja Srinivasan, Kathleen A Jablonski, William C Knowler, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2016
Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOWDevjit Tripathy, Dawn C Schwenke, MaryAnn Banerji, et al.
AIDS Research and Human Retroviruses|June 9, 1998
Hematologic and virologic effects of lineage-specific and non-lineage-specific recombinant human and rhesus cytokines in a cohort of SIVmac239-infected macaquesS Z Bucur, D A Lackey, J W Adams, et al.
Pageof 108